Covance (CVD) Reports In-Line Q3; Guides
More News related to CVD
- Covance (CVD) Enters a Biomarker Alliance and Services Agreement with Rules-Based Medicine
- Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
- Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
- Morning Movers 11/17: ZOOM, SMTL, AGO, ABCW, XJT Higher; INOC, QUIK, PSUN, ERI, FTK, TBUS Lower
- CVD Equipment (CVv) Posts Q3 EPS of $0.02, 1c Lower Y/Y
Covance (NYSE: CVD) reports Q3 EPS of $0.67, in-line with the analyst estimate of $0.67. Revenue for the quarter was $475 million, which compares to the estimate of $469.76 million.
Sees Q4 EPS of $0.64-$0.67, versus the consensus of $0.72.
Related Categories
EarningsGuidance
Stocks Mentioned
-0.58Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
